All Stories

  1. Development and preclinical investigation of vancomycin loaded oxidized cellulose dressing for management of wounds
  2. Artificial protein scaffolds for human therapeutics: drug discovery and delivery strategies
  3. Biomimetic Scaffolds and Extracellular Matrix-Based Strategies for Myofiber Regeneration in Volumetric Muscle Loss
  4. Phage therapy: innovations, challenges, and future directions in combating superbugs and antibiotic resistance
  5. Transformers in drug discovery: fine-tuning ChemBERTa for high-accuracy prediction of solubility, toxicity and binding affinity
  6. Revolutionizing antiviral therapy: harnessing nanotechnology to unlock the power of phytoconstituents
  7. Lipid carrier-based intranasal delivery of calcium channel blockers for Alzheimer’s disease
  8. Novel ethosomal gel formulation for enhanced transdermal delivery of curcumin and cyclosporine: a preclinical approach to rheumatoid arthritis management
  9. Chitosan nanoparticles: a versatile frontier in drug delivery and wound healing across multiple routes
  10. Innovative drug delivery strategies for targeting glioblastoma: overcoming the challenges of the tumor microenvironment
  11. Novel Vesicular Bilosomal Delivery Systems for Dermal/Transdermal Applications
  12. Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges
  13. Formulation development and characterization of luliconazole loaded−mesoporous silica nanoparticles (MCM−48) as topical hydrogel for the treatment of cutaneous candidiasis
  14. Hydrogels based on chitosan
  15. Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
  16. Localized delivery of Erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinoma
  17. pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis
  18. Anti-Tuberculosis Mur Inhibitors: Structural Insights and the Way Ahead for Development of Novel Agents
  19. Targeting Epigenetic Mechanisms: A Boon for Cancer Immunotherapy
  20. Reemergence of monkeypox: prevention and management
  21. Lipid-Based Drug Delivery Systems for Diseases Managements
  22. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability
  23. Colorectal cancer management: strategies in drug delivery
  24. Antimicrobial Nanomaterials for Food Packaging
  25. Current trends in PLGA based long-acting injectable products: The industry perspective
  26. Lanthanide-Doped Upconversion Luminescent Nanoparticles—Evolving Role in Bioimaging, Biosensing, and Drug Delivery
  27. Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance
  28. Development of the immune system in the human embryo
  29. Nanoparticles—Attractive Carriers of Antimicrobial Essential Oils
  30. Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems
  31. Heavy metal toxicity in Buriganga river alters the immunology of Nile tilapia (Oreochromis niloticus L)
  32. Evaluation of the Partial Replacement of Dietary Fish Meal With Fermented or Untreated Soybean Meal in Juvenile Silver Barb, Barbonymus gonionotus
  33. Recent advancements in cellulose-based biomaterials for management of infected wounds
  34. Intervention of 3D printing in health care: transformation for sustainable development
  35. Effects of Total Enteral Nutrition on Early Growth, Immunity, and Neuronal Development of Preterm Infants
  36. Design and Encapsulation of Immunomodulators onto Gold Nanoparticles in Cancer Immunotherapy
  37. Demonstration of Advanced Data Mining Tools for Optimization of Pellets Employing Modified Extrusion-pelletization Technique
  38. Status of inhalable antimicrobial agents for lung infection: progress and prospects
  39. The Impact of an Efflux Pump Inhibitor on the Activity of Free and Liposomal Antibiotics against Pseudomonas aeruginosa
  40. Metallic nanoparticles as drug delivery system for the treatment of cancer
  41. Current and novel therapeutic strategies for the management of cystic fibrosis
  42. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics
  43. Toxicity of Heavy Metal in River Water Alters the Physiological and Immunological Functions in Tilapia, <i>Oreochromis niloticus<i></i></i>
  44. Low stringency tests revealed differential gene expression in red maple (Acer rubrum) treated with low doses of nickel
  45. Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa
  46. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery
  47. Emerging therapeutics for the management of COVID 19
  48. Macrophage targeted nanocarrier delivery systems in HIV therapeutics
  49. Appraisal of different levels of soybean meal in diets on growth, digestive enzyme activity, antioxidation, and gut histology of tilapia (Oreochromis niloticus)
  50. Comparison of Postoperative Liver Function Between Different Dissection Techniques During Laparoscopic Cholecystectomy
  51. Peritoneal GATA6+ macrophages function as a portal for Staphylococcus aureus dissemination
  52. Novel therapeutic approaches for targeting TB and HIV reservoirs prevailing in lungs
  53. Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
  54. Approaches for CNS delivery of drugs – nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment
  55. Antibacterial Properties of Graphene Based Nanomaterials: An Emphasis on Molecular Mechanisms, Surface Engineering and Size of Sheets
  56. Analysis of gene expression in red maple (Acer rubrum) and trembling aspen (Populus tremuloides) populations from a mining region
  57. Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
  58. Process Variables and Design of Experiments in Liposome and Nanoliposome Research
  59. Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies
  60. Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications
  61. PLGA Ethionamide Nanoparticles for Pulmonary Delivery: Development and in vivo evaluation of dry powder inhaler
  62. Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma
  63. Variation in whole DNA methylation in red maple (Acer rubrum) populations from a mining region: association with metal contamination and cation exchange capacity (CEC) in podzolic soils
  64. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability
  65. Potential applications of nanoparticles in cancer immunotherapy
  66. Correction: Identification and treatment of the Staphylococcus aureus reservoir in vivo
  67. Functionalized and graft copolymers of chitosan and its pharmaceutical applications
  68. Identification and treatment of the Staphylococcus aureus reservoir in vivo
  69. Large Eddy Simulation Modeling of Non-Premixed Turbulent Oxy-Fuel Combustion Supplied by Three Separated Jets
  70. Comparative analysis of metal translocation in red maple (Acer rubrum) and trembling aspen (Populus tremuloides) populations from stressed ecosystems contaminated with metals
  71. The role of formate in combatting oxidative stress
  72. Pulmonary drug and vaccine delivery: therapeutic significance and major challenges
  73. Nasal and pulmonary vaccine delivery using particulate carriers
  74. Preparation and evaluation of nanoparticles loaded ophthalmicin situgel
  75. Molecular analysis of red maple (Acer rubrum) populations from a reclaimed mining region in Northern Ontario (Canada): soil metal accumulation and translocation in plants
  76. Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients
  77. Formulation and evaluation of floating tablet of H2-receptor antagonist
  78. Fumarate metabolism and ATP production in Pseudomonas fluorescens exposed to nitrosative stress
  79. Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase
  80. Liposome-Entrapped Antibiotics
  81. Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats
  82. Hydrogen peroxide stress provokes a metabolic reprogramming in Pseudomonas fluorescens: Enhanced production of pyruvate
  83. Liposomal antibiotics for the treatment of infectious diseases
  84. Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity
  85. Efficacy and Safety of Liposomal Clarithromycin and Its Effect on Pseudomonas aeruginosa Virulence Factors
  86. Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
  87. Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection
  88. Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model
  89. Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis
  90. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa
  91. Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa
  92. Treatment of ricin A-chain-induced hepatotoxicity with liposome-encapsulated N-acetylcysteine
  93. Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells
  94. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes
  95. The effect of aminoglycoside antibiotics on the thermodynamic properties of liposomal vesicles
  96. Role of nanocarrier systems in cancer nanotherapy
  97. Characterization of the interaction between liposomal formulations andPseudomonas aeruginosa
  98. The effect of aminoglycoside antibiotics on the thermodynamic properties of liposomal vesicles
  99. Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis
  100. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa
  101. Bismuth–thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa
  102. Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents
  103. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa
  104. Liposomes as a carrier for gentamicin delivery: Development and evaluation of the physicochemical properties
  105. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin
  106. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains
  107. Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting
  108. Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries
  109. Importance of divalent cations in nanolipoplex gene delivery
  110. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia
  111. Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosa
  112. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time–kill study
  113. The Role of Liposomal Antioxidants in Oxidative Stress
  114. Preparation and characterization of dehydration–rehydration vesicles loaded with aminoglycoside and macrolide antibiotics
  115. Recent trends in the lipid-based nanoencapsulation of antioxidants and their role in foods
  116. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients
  117. Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system
  118. The Effect of Different Lipid Components on the In Vitro Stability and Release Kinetics of Liposome Formulations
  119. Disposition of 3 H-Cholesteryl Ether Labeled Liposomes Following Intravenous Administration to Mice: Comparison with an Encapsulated 14 C-Inulin as Aqueous Phase Marker
  120. Short-Term Repeated-Dose Toxicity Profile of Archaeosomes Administered to Mice via Intravenous and Oral Routes
  121. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection
  122. Pseudomonas aeruginosa-induced lung injury: role of oxidative stress
  123. SAFETY OF ARCHAEOSOME ADJUVANTS EVALUATED IN A MOUSE MODEL*
  124. Incorporation rates, stabilities, cytotoxicities and release of liposomal tetracycline and doxycycline in human serum [In Process Citation]
  125. Serotyping clinical isolates of Pseudomonas aeruginosa in relation to infection site antibiotic susceptibility and beta-lactamase production
  126. Preparation, properties and the effects of amikacin, netilmicin and tobramycin in free and liposomal formulations on Gram-negative and Gram-positive bacteria
  127. Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane or isoflurane
  128. Mechanism of Halothane Attenuation of Isometric Tension Induced by Serotonin in Isolated Canine Coronary Artery Rings
  129. Artificial Implants – New Developments and Associated Problems